• Senseonics debuts its 90-day Eversense CGM fiercebiotech
    August 10, 2018
    Barely two months after scoring an FDA nod, Senseonics’ long-term continuous glucose monitor is hitting the market. It is now available in clinics across the U.S.
PharmaSources Customer Service